Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 1,370 shares at $15.10 ($21K) on 2023-02-16, disclosed to the SEC on 2023-02-17.
Seasonal sale ($21k) by Chief Scientific Officer — this insider has traded DCPH in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |
| DCPH | SELL | 2021-02-18 | $25K | — | Filing → |